BioDuro, a global contract research, development and manufacturing organization, has formed an agreement with Porton Pharma Solutions, a provider of custom, cross life-cycle active pharmaceutical ingredient (API) development and cGMP manufacturing services to the global drug industry. Under this agreement, BioDuro will promote and market Porton’s capabilities for pilot and large-scale GMP production of custom APIs and drug intermediates, while Porton will incorporate BioDuro’s arr...